AUCTROL
Filed on Nov 11, 2025
Ophthalmologic preparations; Allergy medication; Pharmaceutical preparations, namely, appetite suppressants; Bronchodilators; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Anti-diabetic pharmaceuticals; Anti-epileptic pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical agents affecting metabolism; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Chemical reagents for medical use
Shanghai Aucta Pharmaceuticals Co., Ltd.
No. 10, Lane 100, Banxia Road, Pudong New Area, Shanghai, CHINA, 201318